The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys

DDC, Free Full-Text

Frontiers The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements

Figure 4 from Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists

Cannabinoid-1 receptor neutral antagonist reduces binge-like

Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity

PDF) The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

CB1 receptor antagonist AM4113 reverts the effects of cannabidiol on cue and stress-induced reinstatement of cocaine-seeking behaviour in mice - ScienceDirect

Neutral antagonism at the cannabinoid 1 receptor: a safer

Figure 4 from Cannabinoid Discrimination and Antagonism by CB1 Neutral and Inverse Agonist Antagonists

The Novel Cannabinoid CB1 Receptor Neutral Antagonist AM4113 Suppresses Food Intake and Food-Reinforced Behavior but Does not Induce Signs of Nausea in Rats

Overcoming the Psychiatric Side Effects of the Cannabinoid CB1 Receptor Antagonists: Current Approaches for Therapeutics Development. - Abstract - Europe PMC

Novel pyrazole derivatives as neutral CB1 antagonists with

A neutral CB1 receptor antagonist reduces weight gain in rat American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats - ScienceDirect